Showing results (121-130 of 188) with videos related to
Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|November 22, 1997
Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility studyM Kajanti, C Blomqvist, H Lehtonen, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 9, 2017
Force measurements during posterior calvarial vault osteodistraction: A novel measurement methodA Ritvanen, M Savolainen, D Nowinski, et al.Journal of Clinical Orthopaedics and Trauma|January 7, 2025
The size of local recurrence influences outcomes in chondrosarcoma: Significant impact observed in grade 2 tumoursG Kask, M K Laitinen, M C Parry, et al.British Journal of Cancer|June 1, 1996
Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomasC Blomqvist, R Huuhtanen, Y Pan, et al.British Journal of Cancer|July 2, 1999
Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factorsT Jahkola, T Toivonen, K von Smitten, et al.British Journal of Cancer|December 1, 1992
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trialC Blomqvist, K Tiusanen, I Elomaa, et al.BMC Cancer|December 12, 2022
Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 casesS Voutilainen, P Heikkilä, J Bartkova, et al.Histopathology|August 23, 2007
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?C Ahlin, K Aaltonen, R-M Amini, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndromeA R Koskinen, E Tukiainen, J Arola, et al.International Journal of Clinical Pharmacology Research|December 31, 2002
Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancerP Kellokumpu-Lehtinen, A Lantto, R Kokko, et al.Pageof 19